Successful use of IFN-γ for refractory systemic infection with Candida tropicalis in a child with AML and CARD9 mutation
- 30 June 2022
- journal article
- Published by Heighten Science Publications Corporation in Archives of Pathology and Clinical Research
- Vol. 6 (1), 013-015
- https://doi.org/10.29328/journal.apcr.1001031
Abstract
Infectious complications remain major causes of treatment-related morbidity and mortality in children with acute myelogenous leukemia (AML) due to the intensive chemotherapeutic regimens needed to treat this disease. Invasive fungal infections (IFI) represent a particularly severe condition that affects 5% - 13% of AML patients with a persistently unacceptable mortality rate of 40%.Keywords
This publication has 5 references indexed in Scilit:
- Successful Allogenic Stem Cell Transplantation in Patients with Inherited CARD9 DeficiencyJournal of Clinical Immunology, 2019
- Patient Susceptibility to Candidiasis—A Potential for Adjunctive ImmunotherapyJournal of Fungi, 2018
- Defect of CARD9 Leads to Impaired Accumulation of Gamma Interferon-Producing Memory Phenotype T Cells in Lungs and Increased Susceptibility to Pulmonary Infection with Cryptococcus neoformansInfection and Immunity, 2014
- Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case seriesBMC Infectious Diseases, 2014
- Gene Expression Profiling to Predict Viridans Group Streptococcal and Invasive Fungal Infection in Pediatric Acute Myeloid Leukemia: A Brief Report from the Children's Oncology GroupActa Haematologica, 2013